Spiess, Birgit
Kleiner, Helga
Flach, Johanna
Fabarius, Alice
Saussele, Susanne
Hofmann, Wolf-Karsten
Seifarth, Wolfgang
Funding for this research was provided by:
José Carreras Leukämie-Stiftung (DJCLS R 14/11 and 13R/2017)
Article History
Received: 30 September 2019
Accepted: 18 March 2020
First Online: 6 April 2020
Compliance with ethical standards
:
: SS received honoraria from Novartis Pharma GmbH, Bristol-Myers Squibb (BMS), Pfizer, and ARIAD and research funding from Novartis Pharma GmbH and BMS. This does not alter our adherence to the <i>Journal of Hematology & Oncology</i> policies on sharing data and materials. The funders had no role in study design, collection, analysis and interpretation of data; writing of the paper and/or decision to submit for publication.
: The study has been approved by the institutional ethics committee (Medizinische Ethikkommission II der Medizinischen Fakultät Mannheim der Ruprecht Karls-Universität Heidelberg, no. 2013-509N-MA).
: All patients provided written informed consent in accordance with the Declaration of Helsinki.